GHCL Limited Overview
| Attribute | Detail | Source |
|---|---|---|
| Legal name | GHCL Limited | [NSE-GOV] |
| Former name | Gujarat Heavy Chemicals Limited (the market still frequently uses this name) | Angel One (Jan 2025); PitchBook |
| Date of incorporation | 14 October 1983 (some databases cite 21 July 1983; MCA/BRSR show 14-10-1983) | [BRSR FY22]; MCA-derived registries |
| Corporate Identity Number (CIN) | L24100GJ1983PLC006513 | Exchange filings |
| Incorporation jurisdiction | Gujarat, India (Registrar of Companies, Ahmedabad) | MCA registry |
| Registered office | "GHCL House", Opp. Punjabi Hall, Near Navrangpura Bus Stand, Navrangpura, Ahmedabad, Gujarat – 380009, India | Exchange filings |
| Corporate office | GHCL House, B-38, Institutional Area, Sector-1, Noida, Uttar Pradesh – 201301, India | Exchange filings |
| Stock exchanges / tickers | National Stock Exchange of India: GHCL; BSE Limited: 500171 | Exchange filings |
| ISIN | INE539A01019 | Exchange data |
| LEI | 335800L2UYNOUH82F930 | financialfilings.com |
| CUSIP | Not applicable (no US listing) | — |
| Index membership | BSE Commodities, Nifty Microcap 250, Nifty Total Market, BSE 1000 | [SCR] |
| Fiscal year end | 31 March | [NSE-GOV] |
| Face value per share | ₹10 | [SCR] |
| Registrar & transfer agent | MUFG Intime India Pvt Ltd (formerly Link Intime), Mumbai | Jhaveri Trade company profile |
| Credit rating | CARE AA-; Stable (long-term) / CARE A1+ (short-term), reaffirmed 10 August 2026 | [CARE26] |
| Statutory auditor | n/d in sources reviewed for FY26 (the 5 May 2026 board agenda included auditor appointments; consult FY26 Annual Report) | [Q4FY26] board notice |
| Internal auditors | Separate firms appointed for Soda Ash and Consumer Products divisions (firm names partially reported; R J Goel & Co. among appointees) | ScanX summary of 5 May 2026 board outcome |
| Website | www.ghcl.co.in | — |
| Only subsidiary | Dan River Properties LLC (USA), 100% | [CARE26]; [BRSR FY24] |
| Promoter group | Dalmia family (Anurag Dalmia, Neelabh Dalmia, Anurag Dalmia HUF, Dalmia Finance Ltd, Dalmia Housing Finance Ltd, Ram Krishna Dalmia Foundation, among others) | Promoter declaration, April 2026 |
| Metric | FY22 | FY24 | FY26 |
|---|---|---|---|
| Total permanent employees (BRSR, standalone, excl. workers) | 744 | 497 | — |
Employee counts are inconsistently reported across sources, reflecting differing scopes (permanent employees vs. permanent workers vs. contract labour) and the 2023 demerger of the labour-intensive textile business.
Notes: FY22 includes the then-integrated yarn business [BRSR FY22]; FY24 is post-demerger [BRSR FY24]. Third-party databases give materially different totals — PitchBook cites 3,439 and EMIS cites 1,037 (2026); an MCA-derived registry cites ~1,298. None of these is company-verified.
Market capitalisation (current)
| Metric | Value | Date / Source |
|---|---|---|
| Share price | ₹463 | Latest Screener snapshot, early October 2026 [SCR] |
| Market capitalisation | ₹4,257 Cr | [SCR] |
| Shares outstanding (derived) | ~9.19 crore shares | Market cap ÷ price; consistent with equity capital of ₹92 Cr at ₹10 FV [SCR FY26] |
| 52-week high / low | ₹668 / ₹419 | [SCR] |
| Cross-check | ₹4,087 Cr at ~₹442 on 28 August 2026 | share.market |
GHCL Limited is India's second-largest producer of soda ash (anhydrous sodium carbonate), operating a single, highly utilised 1.2 million-tonne-per-annum synthetic (Solvay-process) complex at Sutrapada on the Saurashtra coast of Gujarat, with roughly a 26% share of the domestic market. Following the 2023 demerger of its yarn business into GHCL Textiles, it is effectively a pure-play inorganic chemicals company: soda ash accounts for about 98% of standalone revenue, supplemented by refined sodium bicarbonate, industrial salt and a small consumer-products division. Its strategic edge rests on partial captive sourcing of salt, limestone and lignite, best-in-class plant utilisation (~96% in FY26) and an effectively debt-free balance sheet holding over ₹1,100 crore of cash and liquid investments. The company is now diversifying into bromine and vacuum salt, and is preparing a phased 1.1 million-tonne greenfield soda ash plant in Kutch to roughly double capacity by around 2030.
What the company does
GHCL manufactures and sells commodity inorganic chemicals centred on soda ash. Soda ash is a bulk industrial alkali used predominantly in flat and container glass, detergents and soaps, sodium silicate and other chemicals, and — increasingly — in solar glass, lithium carbonate processing (battery supply chains) and flue-gas desulphurisation. GHCL produces both light and dense soda ash grades, as well as refined sodium bicarbonate (RBC), and operates captive salt works that feed the soda ash process. A small consumer products division (edible salt and related packaged goods) remains within the company. [SCR company description; CARE26; Q4FY26 board outcome references to "Soda Ash and Consumer Product divisions"]
The company's own description in recent investor presentations frames it as a "leading soda ash player focused on India's growth market" and emphasises differentiators such as best-in-class capacity utilisation, productivity, operational innovation, customer servicing, and roughly three decades of management continuity. [Q1FY27-PR]
Business model and revenue model
Product vs. service mix: Essentially 100% product revenue. There is no material service, subscription or licensing revenue. Soda ash is ~98.30% of standalone revenue. [SCR, citing company disclosures]
Pricing mechanism: Domestic soda ash prices are not administered; they broadly track the landed price of imported soda ash because India has had neither a structural import duty nor quotas in recent years. Realisations therefore move with global prices (driven by Chinese, Turkish, US and Russian supply), freight rates and the INR/USD exchange rate. [CARE26] The government imposed a Minimum Import Price (MIP) of ₹20,108/tonne (CIF) from 30 December 2024, subsequently extended, which acts as a partial floor. [DGFT Notification 46/2024-25; Outlook Business]
Cost structure: Key variable inputs are salt (partly captive), limestone (partly captive and partly imported), coal, coke, lignite (partly captive) and power/steam; freight is material on both inputs and outputs. [CARE26] Fixed costs are predominantly rupee-denominated, giving operating leverage to any rise in import-parity prices.
Contracting: GHCL supplies leading domestic glass and detergent manufacturers on long-standing relationships; contract tenor and pricing formulas are n/d. [CARE26]
Value-chain position
GHCL sits in the upstream-to-midstream position of the alkali chain: it converts mined/harvested raw materials (salt brine, limestone, coke/lignite for kiln and boiler fuel, ammonia as a process recycle agent in Solvay) into a basic chemical intermediate that is sold business-to-business to downstream manufacturers. Its backward integration (captive salt pans, limestone and lignite leases) is partial; forward integration is limited to sodium bicarbonate and, prospectively, bromine (a co-product extractable from salt bitterns) and vacuum salt.
Customer types and end-markets
| End-market | Role of soda ash | Relevance to GHCL |
|---|---|---|
| Detergents & soaps | Builder/alkali in powders and cakes | Traditional anchor demand; long-standing FMCG relationships [CARE26] |
| Flat & container glass | Flux in glass batch (~20% of batch) | Anchor demand; container glass tied to food/beverage/pharma packaging |
| Solar glass | Flux for low-iron patterned glass | Fastest-growing new vector; management expects solar glass to consume ~8–9% of Indian soda ash demand "soon" [Q1FY27 call summary, Arthneeti] |
| Sodium silicate & chemicals | Feedstock | Steady |
| Lithium carbonate / batteries | Reagent in lithium processing | Emerging; cited by management as a "strong new vector" [Q1FY27-PR] |
| Flue-gas treatment | Sorbent | Cited by CARE as a growth driver through 2031 [CARE26] |
| Sodium bicarbonate customers | Food (baking), pharma, animal feed, fire extinguishers | Served by RBC capacity of 1.2 lakh MTPA [CARE26] |
Independent characterisation
GHCL is best characterised as a low-cost, single-site commodity producer in an oligopolistic but import-exposed national market. Its economics are those of a price-taker whose margin is determined by (i) the spread between import-parity soda ash prices and its delivered input costs, and (ii) its ability to run the plant at near-nameplate capacity. Since FY24 the investment case has shifted from a "chemicals + textiles conglomerate" to a "focused soda ash compounder with optionality": the textile demerger removed a lower-return, cyclical business; cash has accumulated (₹1,113 Cr of cash and liquid investments at FY26 end per [CARE26]); and the forward narrative hinges on the timing and execution of the Kutch greenfield project and the small but high-margin bromine/vacuum salt diversification. The near-term P&L remains hostage to Chinese overcapacity, the trade-remedy regime and West Asia-related freight dislocation.
Strategy
Stated strategic themes
From recent investor presentations and management commentary [Q1FY27-PR; Q4FY26; Q3FY26]:
-
Focus on India's soda ash growth market — capture incremental domestic demand of an estimated 2.5–3.0 lakh tonnes per year (market growing 5–6% p.a.).
-
Cost leadership and operational excellence — best-in-class utilisation, productivity and "operational innovation"; "focus on what is within our control".
-
Capacity doubling via greenfield — from 12 lakh to ~23 lakh MTPA by ~2030 via the Kutch project, raising market share ambition toward ~30%.
-
Adjacent, high-margin diversification — bromine and vacuum salt leveraging salt assets.
-
Disciplined capital allocation — debt-free balance sheet, internal accrual funding, regular dividends and opportunistic buybacks.
-
Sustainability — framework built on climate action, stakeholder centricity and a "zero-harm" safety initiative; EV truck logistics electrification.
-
Trade-policy advocacy — pressing for anti-dumping duties to address import surges.
Initiative register (last 24 months)
| Initiative | Type | Announced / status | Investment / target | Source |
|---|---|---|---|---|
| Kutch greenfield soda ash (Bada, Mandvi) | Capacity expansion | Board approval May 2024; EC received; NGT appeals dismissed 21 Aug 2026; land acquisition delays; "slow progress"; no firm zero date; commissioning by 2030 at earliest | 11 lakh MTPA in two phases; Phase I ~₹4,000 Cr (incl. common infrastructure), Phase II ~₹1,000 Cr; term debt ~₹2,000–2,500 Cr; FY27 spend ~₹100 Cr | [CARE26]; [BSE-2024]; Sahi; Arthneeti |
| Bromine project (Phase 1) | Diversification | In advanced commissioning; COD scheduled Q2 FY27 | ~₹115–120 Cr capex (FY24 guidance) | [Q1FY27-PR]; Arthneeti FY24 call summary |
| Bromine Phase 2 | Diversification | Planned on newly acquired government land; 3–4 years post land formalities | 10,000–12,000 t; capex n/d | Arthneeti Q4 FY26 summary |
| Vacuum salt plant | Diversification | In advanced commissioning; COD scheduled Q2 FY27 | ~₹150–170 Cr capex (FY24 guidance) | [Q1FY27-PR] |
| Zara Zumara salt works | Backward integration | 6,449 ha, 30-year lease (allotted ~2024) | n/d (roic.ai cites ~₹350 Cr salt field) | Q1 FY25 call |
| Sodium bicarbonate expansion | Capacity | Completed FY25 | — | Q1 FY25 call |
| Salt yield improvement programme | Efficiency | Ongoing | — | Q1 FY25 call |
| ₹300 Cr share buyback | Capital return | Completed Nov–Dec 2025 | 41,37,931 shares at ₹725 | [BUYBACK] |
| EV truck initiative / GreenLine partnership | Sustainability / Scope 3 | Oct 2024 onwards | — | Q1 FY27 presentation; roic.ai |
| Supplier ESG programme (with AuthBridge) | Responsible sourcing | Ongoing | All suppliers sign Supplier Code of Conduct | [CARE26]; roic.ai |
| Renewable energy | Decarbonisation | 6.7 MW installed at FY26 end | Further targets n/d | [CARE26] |
| Efficiency & value-added products capex | Maintenance/efficiency | FY27 | ~₹150 Cr | [CARE26] |
Medium-term targets and guidance
Capacity: ~23 lakh MTPA by 2030 (from 12 lakh). [Sahi; Angel One Oct 2025]
Market share ambition: ~30% (from ~26%). [Procurement Resource summary — secondary]
New businesses: ~₹120 Cr revenue in FY27 at 40–45% EBITDA margin. [Q4FY26 call summary — secondary]
Capex: Regular capex historically guided at ~₹250 Cr p.a. excluding greenfield; FY27 ~₹250 Cr (₹150 Cr efficiency/value-added + ₹100 Cr greenfield) per CARE. [CARE26; FY24 call summary]
No formal revenue/EBITDA guidance: is issued by management. CARE's independent base case: total operating income CAGR of ~4–5% and PBILDT of ~₹750–850 Cr p.a. in the medium term. [CARE26]
Products & Services
All products sit within the Inorganic Chemicals segment. Specifications are summarised from public descriptions; grade-level technical data sheets and price lists are n/d.
Guidance on the new businesses: Management guided at the Q4 FY26 call that bromine and vacuum salt would add approximately ₹120 Cr of revenue in FY27 at a 40–45% EBITDA margin. [Q4FY26 call, Arthneeti summary — secondary] At that run-rate the diversification would add roughly ₹50 Cr of EBITDA (derived), about 7% of FY26 EBITDA.
Product Portfolio
| Product | Description & key specifications | Capacity / scale | Target customers | Launch / latest status | Pricing model |
|---|---|---|---|---|---|
Soda Ash – Light | Anhydrous sodium carbonate (Na₂CO₃), low bulk density (~0.5–0.6 t/m³ typical for light grade), produced via Solvay ammonia-soda process | Part of 12 lakh MTPA total soda ash capacity; ~96% utilisation FY26 | Detergents, soaps, sodium silicate, chemicals | Since plant commissioning (late 1980s †) | Spot/contract; tracks landed import price; FY26 average realisation ₹23,709/t (all grades) [CARE26] |
Soda Ash – Dense | Densified grade for glass furnaces (higher bulk density, low dusting) | Part of 12 lakh MTPA | Flat glass, container glass, solar glass | Ongoing | As above |
Refined Sodium Bicarbonate (RBC) | NaHCO₃ refined from soda ash; food/pharma/feed/industrial grades | 1.20 lakh MTPA installed; expansion completed in FY25 | Bakery/food, pharma, animal feed, fire-fighting, leather | Expanded FY25 | Contract/spot; n/d |
Industrial Salt | Solar salt from captive salt works; feedstock for soda ash and merchant sale | 3 lakh MTPA salt production capacity [CARE26]; Zara Zumara 6,449 ha lease adds future capacity | Captive (soda ash brine); chlor-alkali and other users | Ongoing; new Kutch salt works under development (₹350 Cr salt field planned; per roic.ai) | — |
Bromine (new) | Elemental bromine recovered from salt bitterns | Phase 1 capacity n/d; management cites ambition to lift elemental bromine output "north of 18,000 tons" and a Phase-2 bromine project of 10,000–12,000 t on newly acquired government land (3–4 years post land formalities) [Q4FY26 call, Arthneeti summary — secondary] | Flame retardants, pharma, agrochemicals, oil-field chemicals, water treatment | Commercial operations scheduled Q2 FY27 [Q1FY27-PR]; confirmation of COD not yet seen as of 6 Oct 2026 | Global benchmark-linked; n/d |
Vacuum Salt (new) | High-purity evaporated salt (≥99.5% NaCl typical for vacuum salt) | Capacity n/d; combined bromine + vacuum salt capex ~₹300 Cr (vacuum salt ~₹150–170 Cr) [FY24 call summary] | Chlor-alkali membrane cells, food-grade salt, pharma | Commercial operations scheduled Q2 FY27 [Q1FY27-PR] | — |
Consumer Products | Packaged edible salt and allied consumer goods (brand-level detail n/d in sources reviewed) | Small (<2% of revenue) | Retail/FMCG distribution | Ongoing as a separate division with its own internal auditor | MRP-based retail pricing |
Financial Narrative
Basis: Consolidated, ₹ Cr, Ind AS, audited annual figures FY22–FY26 [SCR]. FY22 and FY23 include the textile (yarn) business, which was demerged effective 1 April 2023; FY24–FY26 are continuing soda ash operations only. Note that the company's press-release "net revenue" includes other income (e.g., FY25 "net revenue" ₹3,273 Cr standalone ≈ revenue from operations ₹3,183 Cr + other income ₹88 Cr consolidated).
Income statement
Gross profit: n/d (Indian P&L format does not report cost of goods sold separately in the databases reviewed). Diluted EPS: n/d separately; dilution from ESOPs is immaterial (e.g., 1.96 lakh shares allotted under ESOP in mid-2026, ~0.2% of shares). Operating income (EBIT) is shown in 6.4.
Standalone cross-check: FY26 standalone PAT ₹478.81 Cr (FY25: ₹626.23 Cr, –23.5%); standalone total revenue ₹3,143.93 Cr (FY25: ₹3,273.21 Cr, –3.95%). [Q4FY26; Torus Digital]
Margins and growth
All derived from 6.1. EBIT = EBITDA – depreciation (excludes other income). FY22 revenue growth computed against FY21 revenue of ₹2,491 Cr [SCR]; FY22 profit growth against FY21 PAT of ₹326 Cr. Revenue CAGR FY22–FY26: –5.1% (derived), distorted by the demerger; Screener reports 5-year sales CAGR of ~4% and 3-year CAGR of –12%.
Dividends per share
FY25 and FY26 DPS of ₹12 are company-declared (120% of face value). [FilingReader, Nov 2025; Angel One, May 2026] FY23 ₹17.5 per Simply Wall St headline and consistent with 15% payout on EPS of ₹119.41 (derived); FY24 ₹12 derived from 14% payout on EPS of ₹82.94 — treat as indicative. FY22 payout shown as 0% in [SCR] on a fiscal-year-of-declaration basis; FY22 DPS n/d.
Balance sheet
Sources: [SCR]; cash and liquid investments from [CARE25] (FY24, FY25) and [CARE26] (FY26). Net debt derived. CARE reports FY26 tangible net worth of ₹3,535 Cr and total debt of ₹83 Cr. Short-term vs. long-term debt split: only partially disclosed — the rated term loan outstanding was ₹54.95 Cr (maturing 30 June 2028) as of August 2026, with fund-based working capital limits largely unutilised. [CARE26] Goodwill and intangibles: n/d (not material in sources reviewed). Working capital (current assets – current liabilities): n/d.
Cash flow
Sources: [SCR]; FY26 buyback and dividends paid from [Q4FY26] (management stated it distributed ₹415 Cr to shareholders in FY26 = ₹300 Cr buyback + ₹115 Cr dividends, and repaid ₹335 Cr of borrowings including working-capital lines). Source discrepancy: CARE reports FY26 CFO of ₹719 Cr (FY25: ₹604 Cr) [CARE26], whereas [SCR] shows ₹687 Cr and a filings aggregator shows ₹681 Cr; the difference likely reflects classification (e.g., treatment of interest/dividend receipts or standalone vs. consolidated). FY26 capex of ~₹263–265 Cr was largely directed at the bromine and vacuum salt projects and was funded from internal accruals. [Q4FY26 call] Historical buybacks before FY26 and dividends paid before FY26: n/d in sources reviewed.
Ratios
ROE and ROA derived on average balances from [SCR]; ROCE, working-capital days and CCC from [SCR]. Debt/equity derived; CARE reports gross gearing of 0.03x (FY25) and 0.02x (FY26), and interest coverage (PBILDT/interest) of 54.87x (FY25) and 70.82x (FY26). [CARE26] CARE separately computes the operating cycle at 96 days in FY26 vs. 107 days in FY25 on its own methodology. ROIC: n/d (ROCE used as proxy). Current ratio: n/d. Note: Screener's high inventory days are computed on its expense base and should be read directionally.
Recent quarterly trajectory (standalone, ₹ Cr)
Sources: revenue [Fyers quarterly data]; EBITDA margins Q4 FY25–Q4 FY26 [ScanX summary of Q4 FY26 results]; Q1 FY27 margin derived from company-reported EBITDA ₹233 Cr on net revenue ₹798 Cr [Q1FY27-PR]; PAT [Torus Digital standalone; Q1FY27-PR]. Q1 FY27 PAT includes an exceptional gain of ₹53.62 Cr; profit before exceptional items and tax was ₹203.91 Cr and tax ₹66.35 Cr. [Investywise summary of Q1 FY27 filing] The exceptional item likely relates to the ESOS Trust broker-litigation settlement (April 2026) — nature not confirmed in sources reviewed.
Commentary on trends, inflections and drivers
Revenue. The FY22–FY23 surge (consolidated revenue +52% then +20%) reflected a global soda ash super-cycle triggered by post-pandemic glass/solar demand, Chinese energy curbs and European energy shocks; FY23 also still contained textiles. FY24's 24% decline combines the demerger with the normalisation of global prices as Chinese natural soda ash capacity (notably in Inner Mongolia) came on stream. FY25 and FY26 revenues fell a further 7.7% and 3.7% despite volume growth (~3% in FY26) because average realisation dropped ~7% to ₹23,709/t in FY26. [CARE26] Import share in India has nearly doubled from a historical ~15% to ~25–26%, structurally capping domestic prices. [Outlook Business, 2026]
Margins. EBITDA margin peaked at ~33% in FY23, compressed to ~25% in FY24, recovered to ~28% in FY25 on lower coal/lignite costs and operational efficiency (FY25 standalone EBITDA rose 7% to ₹966 Cr despite revenue down 6% [Indian Chemical News, May 2025]), then compressed to ~22.5% in FY26 on lower realisations and elevated freight costs linked to West Asia disruption. [CARE26] The quarterly trajectory shows the trough in Q3 FY26 (22.7%) and a sharp rebound to ~29% in Q1 FY27 on "better realisation and lower input costs", although management warned that the global conflict will feed into energy and raw material costs and moderate margins as FY27 progresses. [Q1FY27-PR] Management has also noted that while soda ash prices fell 19% in one year, its margin fell only 5%, evidencing a cost-curve advantage. [Outlook Business]
Below the line. Interest cost collapsed from ₹64 Cr (FY22) to ₹9 Cr (FY26) as gross debt fell from ₹788 Cr to ₹83 Cr. Other income spiked to ₹270 Cr in FY24 (likely including one-off gains around the demerger/treasury; composition n/d) before normalising to ₹73–88 Cr. The FY26 effective tax rate (26%) is close to the statutory new-regime rate.
Balance sheet and cash. The balance sheet has de-levered completely; investments rose from ₹17 Cr to ₹1,042 Cr, and CWIP rose to ₹450 Cr as diversification capex accumulated. Cash conversion is strong (CFO/EBITDA ≥86% every year; 124% in FY26). Capital allocation in FY26 was explicitly shareholder-friendly: ₹415 Cr returned (buyback + dividend) against ₹265 Cr of growth/maintenance capex, while cash and liquid investments still rose to ~₹1,113 Cr.
Returns. ROE has fallen from 32% (FY23) to 13% (FY26), a function of both lower earnings and a cash-heavy equity base; the buyback was explicitly intended to "enhance the return on equity". [BUYBACK]
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Income Statement and Margin Analysis (%)
| Metric (INR Cr) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Revenue from operations | 3,778 | 4,545 | 3,447 | 3,183 | 3,064 |
Total operating expenses | 2,797 | 3,048 | 2,596 | 2,306 | 2,375 |
EBITDA (operating profit excl. other income) | 982 | 1,497 | 851 | 877 | 689 |
Other income | 58 | 124 | 270 | 88 | 73 |
Depreciation | 117 | 94 | 102 | 112 | 111 |
Interest | 64 | 39 | 27 | 17 | 9 |
Profit before tax | 859 | 1,489 | 991 | 836 | 642 |
Effective tax rate (%) | 25 | 23 | 20 | 25 | 26 |
Net profit | 647 | 1,142 | 794 | 624 | 472 |
EPS basic (INR) | 67.79 | 119.41 | 82.94 | 65.18 | 51.39 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansMargin Analysis (%)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
EBITDA margin (%) | 26.0 | 32.9 | 24.7 | 27.6 | 22.5 |
EBIT margin (%) | 22.9 | 30.9 | 21.7 | 24.0 | 18.9 |
PBT margin (%) | 22.7 | 32.8 | 28.7 | 26.3 | 21.0 |
Net margin (%) | 17.1 | 25.1 | 23.0 | 19.6 | 15.4 |
Revenue growth YoY (%) | 51.7 | 20.3 | -24.2 | -7.7 | -3.7 |
Net profit growth YoY (%) | 98.5 | 76.5 | -30.5 | -21.4 | -24.4 |
Per-Share Data and Returns & Leverage Ratios (%)
| Metric | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Dividend per share (INR) | — | 17.5 | 12 | 12 | 12 |
Dividend payout ratio (%) | 0 | 15 | 14 | 18 | 23 |
Balance Sheet
| Metric (INR Cr) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Total assets | 4,995 | 5,133 | 3,770 | 4,185 | 4,300 |
Net fixed assets | 2,474 | 1,731 | 1,842 | 1,844 | 1,821 |
Capital work-in-progress | 213 | 109 | 55 | 256 | 450 |
Investments | 17 | 380 | 420 | 651 | 1,042 |
Other assets (incl. inventory, receivables, cash) | 2,292 | 2,914 | 1,453 | 1,435 | 987 |
Equity share capital | 95 | 96 | 96 | 96 | 92 |
Reserves | 2,990 | 3,860 | 2,883 | 3,393 | 3,460 |
Total equity | 3,085 | 3,956 | 2,979 | 3,489 | 3,552 |
Total borrowings | 788 | 361 | 210 | 119 | 83 |
Other liabilities | 1,122 | 816 | 581 | 578 | 665 |
Cash and liquid investments | — | — | 892 | 1,073 | 1,113 |
Net debt (negative = net cash) | — | — | -682 | -954 | -1,030 |
Cash Flow and Margin Analysis (%)
| Metric (INR Cr) | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
Cash flow from operations | 643 | 856 | 797 | 638 | 687 |
Cash flow from investing | -337 | -403 | -534 | -358 | -291 |
Cash flow from financing | -98 | -536 | -338 | -230 | -451 |
Capex (derived: CFO – FCF) | 337 | 350 | 106 | 302 | 263 |
Free cash flow | 306 | 506 | 691 | 336 | 424 |
CFO / EBITDA (%) | 86 | 87 | 116 | 98 | 124 |
Buyback (INR Cr) | 0 | — | 0 | 0 | 300 |
Dividends paid (INR Cr) | — | — | — | — | 115 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
ROE (%) | 23.2 | 32.4 | 22.9 | 19.3 | 13.4 |
ROA (%) | 14.4 | 22.6 | 17.8 | 15.7 | 11.1 |
ROCE (%) | 25 | 35 | 21 | 24 | 18 |
Debt / equity (x) | 0.26 | 0.09 | 0.07 | 0.03 | 0.02 |
Net debt / EBITDA (x) | — | — | -0.80 | -1.09 | -1.49 |
EBITDA / interest (x) | 15.3 | 38.4 | 31.5 | 51.6 | 76.6 |
Asset turnover (x) | 0.84 | 0.90 | 0.77 | 0.80 | 0.72 |
Debtor days | 22 | 18 | 19 | 24 | 21 |
Inventory days | 204 | 177 | 185 | 217 | 199 |
Payable days | 74 | 53 | 55 | 57 | 94 |
Cash conversion cycle (days) | 152 | 142 | 149 | 183 | 126 |
Margin Analysis (%) (Quarterly)
| Metric | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|
Revenue from operations | 781 | 796 | 721 | 757 | 791 | 774 |
EBITDA margin (company-reported, %) | 30.2 | 27.3 | 23.7 | 22.7 | 23.9 | 29.2 |
Net profit | 152.62 | 144.78 | 107.36 | 106.70 | 119.97 | 191.18 |
Valuation Snapshot
| Metric | Value | Source |
|---|---|---|
Current price | ₹463 (early Oct 2026) | [SCR] |
1-year return | –26% | [SCR] |
3-year price CAGR | –2% | [SCR] |
5-year price CAGR | +13% | [SCR] |
10-year price CAGR | +12% | [SCR] |
52-week range | ₹419 – ₹668 | [SCR] |
Buyback price (Nov 2025) | ₹725 (stock now ~36% below) | [BUYBACK] |
Reference points | ₹712.85 (1 Jan 2025); ₹519.05 (5 May 2026); ~₹442 (28 Aug 2026) | Angel One; share.market |
Metric | FY22 | FY23 |
EPS (INR) | 67.79 | 119.41 |
Book value per share (₹, derived) | 324.7 | 412.1 |
Valuation Multiples
| Multiple | GHCL | Basis |
|---|---|---|
P/E (trailing) | 9.0x | [SCR] reported 9.01 |
P/B | 1.20x | ₹463 / ₹386 BVPS [SCR] |
Enterprise value | ~₹3,227 Cr | Mcap ₹4,257 Cr + debt ₹83 Cr – cash & liquid investments ₹1,113 Cr |
EV / EBITDA (FY26) | ~4.7x | ₹3,227 Cr / ₹689 Cr |
EV / Sales (FY26) | ~1.05x | ₹3,227 Cr / ₹3,064 Cr |
Dividend yield | 2.59% | [SCR] |
Peer reference | Tata Chemicals: loss-making on reported FY26 basis (P/E not meaningful) | Tata Chemicals FY26 |
Share Price & Returns
| Date | Size | Price | Shares | Method | Status |
|---|---|---|---|---|---|
1 Nov 2025 | ₹300 Cr (8.73% of standalone paid-up capital + free reserves) | ₹725 | 41,37,931 (~4.31% of equity) | Tender offer, proportionate; 15% small-shareholder reservation | Completed Nov–Dec 2025 |
Credit Ratings
| Agency | Instrument | Rating | Outlook | Date |
|---|---|---|---|---|
CARE Ratings | Long-term / short-term bank facilities (₹825 Cr) | CARE AA- / CARE A1+ | Stable | Reaffirmed 10 Aug 2026 |
CARE Ratings | Long-term term loan (₹54.95 Cr, reduced from ₹85.65 Cr) | CARE AA- | Stable | Reaffirmed 10 Aug 2026 |
Moody's / S&P / Fitch | — | Not rated | — | — |
Capital Instruments
| Instrument | Amount (INR Cr) | Maturity |
|---|---|---|
Term loan | 54.95 | 30 Jun 2028 |
Scheduled term-debt repayments | ~30 p.a. | Medium term |
Fund-based working capital limits | 450 (largely unutilised; >₹450 Cr unutilised at 30 Jun 2026) | Annual renewal |
Analyst Conclusions
Management guidance (latest)
-
Long-term fundamentals positive; domestic demand to grow 5–6% p.a. with solar glass a key new vector. [Q1FY27-PR]
-
Q1 FY27 margin improvement driven by realisation and lower input costs, but margins expected to moderate as FY27 progresses due to conflict-driven energy and raw material costs. [Q1FY27-PR]
-
Bromine and vacuum salt to start commercial operations in Q2 FY27; ~₹120 Cr revenue at 40–45% EBITDA margin in FY27. [Q1FY27-PR; Q4FY26 call summary]
-
Greenfield soda ash making "slow progress"; no clear timeline due to land acquisition; commissioning by 2030 at the earliest. [Q1FY27-PR; Q1 FY27 call summary]
Consensus expectations
Sell-side consensus: n/d. Independent reference point — CARE's base case of TOI growth of ~4–5% CAGR and PBILDT of ~₹750–850 Cr p.a. in the medium term. [CARE26] For context, FY26 PBILDT was ₹693 Cr, so CARE implies a 8–23% EBITDA recovery from the FY26 base.
Bull case
-
Import-parity reflation: INR weakness and elevated freight lift landed import prices; with rupee-denominated fixed costs and ~96% utilisation, GHCL's operating leverage is high — Q1 FY27 already showed EBITDA margin recovering to ~29% from 22.7% two quarters earlier.
-
Trade-remedy catalyst: Implementation of DGTR's recommended US$79–113/t anti-dumping duties, or a successful China-focused petition, would directly reprice the domestic market at a time when imports hold a 25–26% share.
-
Cheap, cash-rich optionality: At ~4.7x EV/EBITDA and ~1.2x book, with ~₹1,030 Cr net cash (~24% of market cap), investors pay little for the greenfield, the bromine/vacuum salt ramp or future capital returns.
Bear case
-
Structural price ceiling: Chinese natural soda ash capacity and redirected exports may keep global prices depressed for years; Tata Chemicals' FY26 US goodwill impairment of ₹1,837 Cr signals how deep the trough is.
-
Growth vacuum: With the plant at
96% utilisation and the greenfield slipping toward 2030+, volume growth is negligible; new businesses (₹120 Cr revenue) are under 4% of revenue. -
Capital allocation risk: A ₹4,000–5,000 Cr project (some reports say ₹6,500 Cr) is larger than the entire current market capitalisation; cost overruns, land delays or a poorly timed commissioning into a global glut could dilute returns and introduce ₹2,000–2,500 Cr of debt.
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable |
|---|---|
| Late Oct / early Nov 2026 | Q2 FY27 results — confirmation of bromine and vacuum salt COD; margin trajectory vs. guided moderation |
| FY27 | Finance Ministry decision on soda ash anti-dumping duties; MIP renewal/expiry |
| FY27 | Greenfield: land acquisition completion, financial closure, EPC award, "zero date" announcement |
| FY27 | Any further appeal against NGT ruling |
| Ongoing | Landed import price (China/Turkey FOB + freight + INR); domestic realisation per tonne vs. FY26's ₹23,709/t |
| Ongoing | Coal, coke, lignite, salt and freight costs (West Asia) |
| Q3 FY28 (beyond window, but priced in early) | Tata Chemicals' 350 kt Mithapur dense ash commissioning |
| Ongoing | Capital allocation — further buybacks vs. cash conservation for greenfield |
| Aug 2027 | Next CARE rating review |
Analyst verdict
GHCL today is a well-run, cash-generative commodity franchise trading at a valuation that already discounts a prolonged downcycle. The core facts are unambiguous: the Sutrapada plant runs at roughly 96% utilisation, the company holds about ₹1,113 crore of cash and liquid investments against ₹83 crore of debt, operating cash flow consistently exceeds most of EBITDA, and management returned ₹415 crore to shareholders in FY26 while still funding diversification capex internally. Its cost discipline — a 19% fall in soda ash prices translating into only a 5% margin hit — is the hallmark of a low-cost synthetic producer.
Against that, the earnings line has deteriorated for three straight years, from ₹1,142 crore of profit in FY23 to ₹472 crore in FY26, because GHCL is a price-taker in a market where imports now hold a quarter of share and the government's protective tools have been slow and leaky. The near-term P&L hinges on variables management does not control — Chinese export pricing, freight, the rupee and trade-remedy decisions. The long-term equity story hinges on the Kutch greenfield, whose timeline has slipped repeatedly despite the August 2026 NGT win and whose cost is now larger than the company's market value.
On balance, the risk-reward is asymmetric in investors' favour at ~4.7x EV/EBITDA, ~1.2x book and a ~2.6% dividend yield, provided capital allocation remains disciplined. The base case is modest EBITDA recovery toward CARE's ₹750–850 crore range as bromine and vacuum salt ramp up and import parity firms; upside comes from anti-dumping duties or a sustained freight-driven price reset; downside is bounded by the net-cash balance sheet but would materialise through a debt-funded greenfield commissioned into a global glut. The stock is best viewed as a value-with-catalysts holding, with Q2 FY27 commissioning confirmation and greenfield financial closure as the critical proof points to monitor.
APPENDIX A — DATA DISCREPANCIES NOTED
| Item | Source A | Source B | Treatment |
|---|---|---|---|
| Greenfield capacity | 5 lakh MTPA (2023 announcement) | 5.5 lakh MTPA Phase I; 11 lakh MTPA total in two phases ([BSE-2024]; [CARE26]) | Used CARE/BSE (latest primary) |
| Greenfield cost | ₹4,000 Cr Phase I + ~₹1,000 Cr Phase II [CARE26] | ₹6,500 Cr for 1.1 MTPA (media, Oct 2025) | Both reported; CARE preferred |
| FY26 operating cash flow | ₹719 Cr [CARE26] | ₹687 Cr [SCR]; ₹681 Cr (filings aggregator) | Screener used in tables; discrepancy flagged |
| Revenue definition | Company "net revenue" includes other income (e.g., FY25 ₹3,273 Cr) | Revenue from operations (FY25 ₹3,183 Cr consolidated) | Revenue from operations used in tables |
| Incorporation date | 14 Oct 1983 (MCA/BRSR) | 21 Jul 1983 (EMIS) | MCA/BRSR used |
| Employees | 497 permanent employees (BRSR FY24) | 3,439 (PitchBook); 1,037 (EMIS 2026); ~1,298 (registry) | BRSR used |
| Headquarters | Registered office Ahmedabad | Several databases cite Noida (corporate office) | Both disclosed |
| Q1 FY26 standalone PAT | ₹144.78 Cr (Torus standalone series) | ₹144.11 Cr (cited as standalone in one news item; matches consolidated series) | ₹144.78 Cr used for standalone |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Position | Category | Tenure / key dates | Background | Source |
|---|---|---|---|---|---|
Anurag Dalmia | Non-Executive Chairman | Promoter, Non-Executive | Chairman since 30 Jun 2023; committee member since 29 Jul 2021; also Chairman of GHCL Textiles since 6 May 2024 | Shri Ram College of Commerce; Director, Dalmia Foundation, Bharat Explosives Ltd; former Vice Chairman, Golden Tobacco (2011–14); holds ~1.25 lakh GHCL shares (0.14%) | MarketScreener; [NSE-GOV] |
R S (Ravi Shanker) Jalan | Managing Director | Executive | Long-serving MD (management average tenure ~13.7 years per Simply Wall St) | Chartered accountant by background (†); public face of the company on industry policy (MIP/ADD) | [CARE25]; company releases |
Raman Chopra | CFO & Executive Director (Finance) | Executive | Long-serving; also described by CARE as linked to GHCL Textiles management | Finance leadership; leads earnings calls with MD | [Q1FY27 call]; [CARE25] |
Neelabh Dalmia | Executive Director (Whole-Time Director) | Promoter, Executive | On board since 2005 (committee data show 20-Jul-2005); reappointed WTD Oct 2024 | Born 16 Aug 1983 (age 43); son of Anurag Dalmia | NSE filing 29 Oct 2024 |
Vijaylaxmi Joshi | Independent Director | Independent, Non-Executive | — | Retired senior civil servant (†) | Choice India |
Dr. Manoj Vaish | Independent Director | Independent, Non-Executive | — | Former financial-services executive (†) | Choice India |
Arun Kumar Jain | Independent Director | Independent, Non-Executive | — | — | Choice India; [NSE-GOV] |
Justice Ravindra Singh (Retd.) | Independent Director (status at GHCL to be confirmed) | Independent | Tenure on GHCL Textiles board ended 31 Mar 2026 | Retired High Court judge | [NSE-GOV] |
Executive Leadership Team
| Name | Role | Source |
|---|---|---|
Bhuwneshwar Mishra | VP – Sustainability & Company Secretary | [BSE-2024] |
Shalabh Agarwal | Senior management (role n/d) | Simply Wall St |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
30 Jun 2023 | Anurag Dalmia becomes Non-Executive Chairman | Generational transition within promoter family (†: succeeding Sanjay Dalmia) |
29 Oct 2024 | Neelabh Dalmia reappointed WTD/ED | Continuity of promoter executive presence |
1 Apr 2026 | Justice Ravindra Singh ceases as director of GHCL Textiles (tenure completed) | Sister-company governance change |
Shareholding Trend
| Holder category (%) | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Jun 2026 |
|---|---|---|---|---|---|
Promoters & promoter group | 19.04 | 18.98 | 18.98 | 19.83 | 19.81 |
Foreign institutional investors | 26.07 | 26.41 | 25.67 | 25.22 | 22.40 |
Mutual funds | 8.80 | 8.81 | 8.97 | 7.90 | — |
Other domestic institutions | 1.31 | 1.48 | 1.56 | 1.60 | 1.70 |
Retail and others | 44.79 | 44.33 | 44.82 | 45.45 | 46.50 |
Major Shareholders
| Rank | Holder | Value held (INR Cr) | Implied stake (%, derived on ₹4,040 Cr mcap) |
|---|---|---|---|
| 1 | DSP Small Cap Fund | 103.24 | 2.6 |
| 2 | Franklin India Small Cap Fund | 72.55 | 1.8 |
| 3 | DSP ELSS Tax Saver Fund | 57.46 | 1.4 |
| 4 | UTI Large & Mid Cap Fund | 55.57 | 1.4 |
| 5 | UTI Aggressive Hybrid Fund | 47.51 | 1.2 |
| 6 | UTI Retirement Fund | 19.14 | 0.5 |
| 7 | ICICI Prudential Smallcap Fund | 17.26 | 0.4 |
| 8 | HDFC Dividend Yield Fund | 16.80 | 0.4 |
| 9 | Motilal Oswal Nifty Microcap 250 Index Fund | 9.26 | 0.2 |
| 10 | Groww Nifty Total Market Index Fund | 0.06 | 0.0 |
Competitive Landscape
Key Competitors
| Competitor | Type / listing | Soda ash position | Comparative scale (latest available) | Relative positioning vs GHCL | Source |
|---|---|---|---|---|---|
Tata Chemicals Ltd | Listed (NSE: TATACHEM) | Largest Indian producer (Mithapur, Gujarat); produced 1 MTPA in FY26; dense soda ash expansion of 350 kt at Mithapur targeted Q3 FY28; global operations in US (natural), UK, Kenya | FY26 consolidated revenue ₹14,584 Cr (–2%); consolidated net loss ₹1,715 Cr after ₹1,956 Cr exceptional charges | Larger, diversified (incl. Rallis agrochemicals); India business stronger than overseas; capacity addition is a competitive threat | Tata Chemicals FY26 release; Q4 FY26 deck |
Nirma Ltd | Private | Major producer (Bhavnagar/Porbandar, Gujarat; also captive detergent consumption) | n/d (private) | Integrated detergent user; price setter in light ash | — |
DCW Ltd | Listed | Soda ash producer (Dhrangadhra, Gujarat †); co-petitioner with GHCL in trade remedies | — | Smaller, more diversified (caustic, PVC) | Chemexcil |
RSPL Ltd (Ghari) | Private | Soda ash producer (Kutch †); integrated with Ghari detergents | — | Integrated detergent player | Chemexcil |
Chinese producers (e.g., Inner Mongolia natural soda ash plants; Shandong Haihua) | Listed/private, China | China is the world's largest producer; large new natural ash capacity driving global surplus | — | Primary source of import pressure | Outlook Business |
Turkish producers (ETI Soda, Kazan Soda Elektrik — WE Soda group) | Private/listed (UK-listed WE Soda plans) | Low-cost natural soda ash exporters | — | Target of DGTR findings (Jan 2021) | DGTR via Chemexcil |
US natural soda ash exporters (Genesis Alkali, Ciner/Sisecam Wyoming, Tata Chemicals North America) | Various | Natural trona-based, low cost | — | Export pressure into Asia | DGTR; Tata Chemicals |
Russian producers (e.g., Bashkir Soda) | Private | Exporter subject to DGTR findings | — | Import competition | ScanX (DGTR findings) |
Iranian producers | Various | Exporter subject to DGTR findings | — | Import competition | ScanX (DGTR findings) |
Solvay (Belgium) | Listed | Global synthetic soda ash leader | — | Limited direct India presence | — |
Peer Comparison FY2026
| Metric | GHCL | Tata Chemicals (consolidated) |
|---|---|---|
Revenue (INR Cr) | 3,064 | 14,584 |
Revenue growth YoY (%) | –3.7 | –2.0 |
EBITDA margin (%) | 22.5 | Low double digits (Q4 FY26 EBITDA ₹274 Cr on ₹3,438 Cr ≈ 8%) |
Net margin (%) | 15.4 | Negative (net loss ₹1,715 Cr) |
India soda ash capacity / output | 1.2 MTPA capacity, ~96% utilisation | ~1.0 MT production at Mithapur in FY26 |
Net debt | Net cash ~₹1,030 Cr | — |



